53

Paushak LtdBOM 532742 Stock Report

Last reporting period 31 Mar, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.083

Micro

Exchange

XBOM - Bombay Stock Exchange

532742.BO Stock Analysis

53

Attractive

Based on Eyestock quantitative analysis, 532742.BO`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

108/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

25.7 %

Undervalued

Market cap $B

0.083

Dividend yield

0.36 %

Shares outstanding

3.08 B

Paushak Ltd. engages in the development and manufacturing of phosgene based specialty chemicals and intermediates. The company is headquartered in Vadodara, Gujarat and currently employs 335 full-time employees. The company went IPO on 2006-05-11. The firm is engaged in the business of manufacturing phosgene-based specialty chemicals. The firm serves various industries, such as pharmaceuticals, agrochemicals, performance and custom synthesis. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate and myristyl chloroformate. The firm's isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride and dimethyl carbamoyl chloride. The firm's carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent and dicyclohexyl carbodiimide.

View Section: Eyestock Rating